SECURITIES PURCHASE
AGREEMENT
This Securities Purchase Agreement (this “
Agreement ”) is dated as of September 8, 2009, between
Repros Therapeutics Inc., a Delaware corporation (the “
Company ”), and each purchaser identified on the
signature pages hereto (each, including its successors and assigns,
a “ Purchaser ” and collectively the “
Purchasers ”).
WHEREAS, subject to the terms and conditions set
forth in this Agreement and pursuant to an effective registration
statement under the Securities Act of 1933, as amended (the “
Securities Act ”), the Company desires to issue and
sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the
Company as more fully described in this Agreement.
NOW, THEREFORE, IN CONSIDERATION of the mutual
covenants contained in this Agreement, and for other good and
valuable consideration the receipt and adequacy of which are hereby
acknowledged, the Company and each Purchaser agree as
follows:
ARTICLE I.
DEFINITIONS
1.1
Definitions . In addition to the terms defined
elsewhere in this Agreement, for all purposes of this Agreement,
the following terms have the meanings set forth in this Section
1.1:
“ Affiliate ” means any
Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under
Rule 405 under the Securities Act.
“ Board of Directors ” means
the board of directors of the Company.
“ Business Day ” means any
day except any Saturday, any Sunday, any day which is a federal
legal holiday in the United States or any day on which banking
institutions in the State of New York are authorized or required by
law or other governmental action to close.
“ Closing ” means the closing
of the purchase and sale of the Securities pursuant to Section
2.1.
“ Closing Date ” means the
Trading Day on which all of the Transaction Documents have been
executed and delivered by the applicable parties thereto, and all
conditions precedent to (i) the Purchasers’ obligations to
pay the Subscription Amount and (ii) the Company’s
obligations to deliver the Securities, in each case, have been
satisfied or waived.
“ Commission ” means the
United States Securities and Exchange Commission.
“ Common Stock ” means the
common stock of the Company, $0.001 par value per share, and any
other class of securities into which such securities may hereafter
be reclassified or changed.
“ Common Stock Equivalents ”
means any securities of the Company which would entitle the holder
thereof to acquire at any time Common Stock, including, without
limitation, any debt, preferred stock, rights, options, warrants or
other instrument that is at any time convertible into or
exercisable or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“ Company Counsel ” means
Winstead PC, with offices located at 24 Waterway Avenue, Suite 500,
The Woodlands, TX 77380.
“ Evaluation Date ” shall
have the meaning ascribed to such term in Section
3.1(r).
“ Exchange Act ” means the
Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.
“ Exempt Issuance ” means the
issuance of (a) shares of Common Stock or options to employees,
officers or directors of the Company pursuant
to any 401k, stock or option plan duly adopted for such purpose, by
a majority of the non-employee members of the Board of Directors or
a majority of the members of a committee of non-employee directors
established for such purpose, (b) securities upon the exercise or
exchange of or conversion of any Securities issued hereunder and/or
other securities exercisable or exchangeable for or convertible
into shares of Common Stock issued and outstanding on the date of
this Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such
securities or to decrease the exercise price, exchange price or
conversion price of such securities, (c) securities issued pursuant
to stock splits, stock dividends or distributions,
recapitalizations and similar events affecting the Common Stock and
(d) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors
of the Company, provided that any such issuance shall only be to a
Person (or to the equityholders of a Person) which is, itself or
through its subsidiaries, an operating company or an asset in a
business synergistic with the business of the Company and shall
provide to the Company additional benefits in addition to the
investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing
in securities.
“ GAAP ” shall have the
meaning ascribed to such term in Section 3.1(h).
“ Ladenburg ” shall have the
meaning ascribed to such term in Section 5.8.
“ Ladenburg Party ” shall
have the meaning ascribed to such term in Section 5.8.
“ Liens ” means a lien,
charge, security interest, encumbrance, right of first refusal,
preemptive right or other restriction, other than restrictions
imposed by securities laws.
“ Material Adverse Effect ”
shall have the meaning assigned to such term in Section
3.1(b).
“ Participation Maximum ”
shall have the meaning ascribed to such term in Section
4.10(a).
“ Per Share Purchase Price ”
equals $0.65 , subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar
transactions of the Common Stock that occur after the date of this
Agreement.
“ Person ” means an
individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or
subdivision thereof) or other entity of any kind.
“ Pre-Notice ” shall have the
meaning ascribed to such term in Section 4.10(b).
“ Pro Rata Portion ” shall
have the meaning ascribed to such term in Section
4.10(e).
“ Proceeding ” means an
action, claim, suit, investigation or proceeding (including,
without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or
threatened.
“ Prospectus ” means the base
prospectus filed with the Registration Statement.
“ Prospectus Supplement ”
means the supplement to the Prospectus complying with Rule 424(b)
of the Securities Act that is filed with the Commission and
delivered by the Company to each Purchaser prior to or at the
Closing.
“ Purchaser Party ” shall
have the meaning ascribed to such term in Section 4.6.
“ Registration Statement ”
means the effective registration statement with Commission file No.
333-155265 which registers the sale of the Shares to the
Purchasers.
“ Required Approvals ” shall
have the meaning ascribed to such term in Section
3.1(e).
“ Rule 144 ” means Rule 144
promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or
regulation hereafter adopted by the Commission having substantially
the same effect as such Rule.
“ Rule 424 ” means Rule 424
promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended or interpreted from time to time, or any
similar rule or regulation hereafter adopted by the Commission
having substantially the same purpose and effect as such
Rule.
“ SEC Reports ” shall have
the meaning ascribed to such term in Section 3.1(h).
“ Securities ” means the
Shares issuable hereunder.
“ Securities Act ” means the
Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.
“ Shares ” means the shares
of Common Stock issued or issuable to each Purchaser pursuant to
this Agreement.
“ Short Sales ” means all
“short sales” as defined in Rule 200 of Regulation SHO
under the Exchange Act (but shall not be deemed to include the
location and/or reservation of borrowable shares of Common
Stock).
“ Subscription Amount ”
means, as to each Purchaser, the aggregate amount to be paid for
Shares purchased hereunder as specified below such
Purchaser’s name on the signature page of this Agreement and
next to the heading “Subscription Amount,” in United
States dollars and in immediately available funds.
“ Subsequent Financing ”
shall have the meaning ascribed to such term in Section
4.10(a).
“ Subsequent Financing Notice
” shall have the meaning ascribed to such term in Section
4.10(b).
“ Subsidiary ” means
any subsidiary of the Company as set forth in the SEC Reports, and
shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date
hereof.
“ Trading Day ” means a day
on which the principal Trading Market is open for
trading.
“ Trading Market ”
means any of the following markets or exchanges on which the Common
Stock is listed or quoted for trading on the date in question: the
NYSE Amex, the Nasdaq Capital Market, the Nasdaq Global Market, the
Nasdaq Global Select Market, or the New York Stock Exchange (or any
successors to any of the foregoing).
“ Transaction Documents ”
means this Agreement and any other documents or agreements executed
in connection with the transactions contemplated
hereunder.
“ Transfer Agent ” means
Computershare Trust Company, the current transfer agent of the
Company, with a mailing address of 350 Indiana Street, Suite 800,
Golden, Colorado 80401 and a facsimile number of
303-262-0610, and any successor transfer agent of the
Company.
“ WS ” means Weinstein Smith
LLP with offices located at 420 Lexington Avenue, Suite 2620, New
York, New York 10170-0002.
ARTICLE II.
PURCHASE AND SALE
2.1
Closing . On the Closing Date, upon the terms and
subject to the conditions set forth herein, substantially
concurrent with the execution and delivery of this Agreement by the
parties hereto, the Company agrees to sell, and the Purchasers,
severally and not jointly, agree to purchase, up to an aggregate of
1,500,000 Shares. Each Purchaser shall deliver to the
Company, via wire transfer of immediately available funds equal to
such Purchaser’s Subscription Amount as set forth on the
signature page hereto executed by such Purchaser and the Company
shall deliver to each Purchaser its respective Shares as determined
pursuant to Section 2.2(a), and the Company and each Purchaser
shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and
conditions set forth in Sections 2.2 and 2.3, the Closing shall
occur at the offices of WS or such other location as the parties
shall mutually agree.
2.2
Deliveries .
(a) On
or prior to the Closing Date, the Company shall deliver or cause to
be delivered to each Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
legal opinion of Company Counsel, in substantially the form of
Exhibit B hereto;
(iii) a
copy of the irrevocable instructions to the Transfer Agent
instructing the Transfer Agent to deliver via the Depository Trust
Company Deposit Withdrawal Agent Commission System (“
DWAC ”) Shares equal to such Purchaser’s
Subscription Amount divided by the Per Share Purchase Price,
registered in the name of such Purchaser; and
(iv) the
Prospectus and Prospectus Supplement (which may be delivered in
accordance with Rule 172 under the Securities Act).
(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause
to be delivered to the Company the following:
(i) this
Agreement duly executed by such Purchaser; and
(ii) such
Purchaser’s Subscription Amount by wire transfer to the
account as specified in writing by the Company.
(a) The
obligations of the Company hereunder in connection with the Closing
are subject to the following conditions being met:
(i) the
accuracy in all material respects when made and on the Closing Date
of the representations and warranties of the Purchasers contained
herein (unless as of a specific date therein);
(ii) all
obligations, covenants and agreements of each Purchaser required to
be performed at or prior to the Closing Date shall have been
performed in all material respects; and
(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b)
of this Agreement.
(b) The
respective obligations of the Purchasers hereunder in connection
with the Closing are subject to the following conditions being
met:
(i) the
accuracy in all material respects when made and on the Closing Date
of the representations and warranties of the Company contained
herein (unless as of a specific date therein);
(ii) all
obligations, covenants and agreements of the Company required to be
performed at or prior to the Closing Date shall have been performed
in all material respects;
(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of
this Agreement;
(iv) there
shall have been no Material Adverse Effect with respect to the
Company since the date hereof; and
(v) from
the date hereof to the Closing Date, trading in the Common Stock
shall not have been suspended by the Commission or the
Company’s principal Trading Market (except for any suspension
of trading of limited duration agreed to by the Company, which
suspension shall be terminated prior to the Closing), and, at any
time prior to the Closing Date, trading in securities generally as
reported by Bloomberg L.P. shall not have been suspended or
limited, or minimum prices shall not have been established on
securities whose trades are reported by such service, or on any
Trading Market, nor shall a banking moratorium have been declared
either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of
hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any
financial market which, in each case, in the reasonable judgment of
each Purchaser, makes it impracticable or inadvisable to purchase
the Securities at the Closing.
ARTICLE III.
REPRESENTATIONS AND
WARRANTIES
3.1
Representations and Warranties of the Company
. The Company hereby makes the following representations
and warranties to each Purchaser:
(a)
Subsidiaries . The Company does not own, directly
or indirectly, any Subsidiaries.
(b)
Organization and Qualification . The Company is
an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of
its incorporation or organization, with the requisite power and
authority to own and use its properties and assets and to carry on
its business as currently conducted. The Company is not
in violation or default of any of the provisions of its certificate
of incorporation or bylaws. The Company is duly
qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, would not
reasonably be expected to result in: (i) a material adverse effect
on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of
operations, assets, business or condition (financial or otherwise)
of the Company or (iii) a material adverse effect on the
Company’s ability to perform in any material respect its
obligations under any Transaction Document (any of (i), (ii) or
(iii), a “ Material Adverse Effect ”). No
Proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.
(c)
Authorization; Enforcement . The Company has the
requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction
Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly
authorized by all necessary action on the part of the Company and
no further action is required by the Company, the Board of
Directors or the Company’s stockholders in connection
therewith other than in connection with the Required
Approvals. Each Transaction Document to which it is a
party has been (or upon delivery will have been) duly executed by
the Company and, when delivered in accordance with the terms hereof
and thereof, will constitute the valid and binding obligation of
the Company enforceable against the Company in accordance with its
terms, except (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer, fraudulent conveyance and other laws of
general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other
equitable remedies and (iii) insofar as indemnification and
contribution provisions may be limited by applicable
law.
(d)
No Conflicts . The execution, delivery and
performance by the Company of the Transaction Documents, the
issuance and sale of the Securities and the consummation by it of
the transactions contemplated hereby and thereby to which it is a
party do not and will not (i) conflict with or violate any
provision of the Company’s certificate of incorporation or
bylaws, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default)
under, result in the creation of any Lien upon any of the
properties or assets of the Company, or give to others any rights
of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company debt or
otherwise) or other understanding to which the Company is a party
or by which any property or asset of the Company is bound or
affected, or (iii) subject to the Required Approvals, conflict with
or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company is subject (including
federal and state securities laws and regulations), or by which any
property or asset of the Company is bound or affected; except in
the case of each of clauses (ii) and (iii), such as would not have
or reasonably be expected to result in a Material Adverse
Effect.
(e)
Filings, Consents and Approvals . The Company is
not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with,
any court or other federal, state, local or other governmental
authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction
Documents, other than: (i) the filings required pursuant to Section
4.2 of this Agreement, (ii) the filing with the Commission of the
Prospectus Supplement, (iii) application(s) to each applicable
Trading Market for the listing of the Securities for trading
thereon in the time and manner required thereby and (iv) such
filings as are required to be made under applicable state
securities laws (collectively, the “ Required
Approvals ”).
(f)
Issuance of the Securities; Registration . The
Shares are duly authorized and, when issued and paid for in
accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company. The Company has
reserved from its duly authorized capital stock the maximum number
of shares of Common Stock issuable pursuant to this
Agreement. The Company has prepared and filed the
Registration Statement in material conformity with the requirements
of the Securities Act, including the Prospectus, and such
amendments and supplements thereto as may have been required prior
to the date of this Agreement. The Registration
Statement was declared effective under the Securities Act on
November 26, 2008 (the “ Effective Date ”) and
no stop order preventing or suspending the effectiveness of the
Registration Statement or suspending or preventing the use of the
Prospectus has been issued by the Commission and no proceedings for
that purpose have been instituted or, to the actual knowledge of
the Company, are threatened by the Commission. The
Company, if required by the rules and regulations of the
Commission, proposes to file the Prospectus Supplement, with the
Commission pursuant to Rule 424(b). At the time the
Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the
Registration Statement and any amendments thereto conformed and
will conform in all material respects to the requirements of the
Securities Act and did not and will not contain any untrue
statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements
therein not misleading; and the Prospectus and any amendments or
supplements thereto, at time the Prospectus or any amendment or
supplement thereto was issued and at the Closing Date, conformed
and will conform in all material respects to the requirements of
the Securities Act and did not and will not contain an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in light of the
circumstances under which they were made, not
misleading.
(g)
Capitalization . The capitalization of the
Company is substantially as set forth in the Prospectus Supplement,
as updated by the SEC Reports. As of the date of the
Agreement, the Company has not issued any capital stock since it
filed its most recently filed periodic report under the Exchange
Act, other than pursuant to the exercise of employee stock options
under the Company’s stock option plans, the issuance of
shares of Common Stock to employees pursuant to the Company’s
employee stock purchase plans and pursuant to the conversion and/or
exercise of Common Stock Equivalents outstanding as of the date of
the most recently filed periodic report under the Exchange
Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction
Documents. Except as disclosed in the SEC Reports, as a
result of the purchase and sale of the Securities or pursuant to
equity compensation plans or agreements filed as exhibits to the
SEC Reports, there are no outstanding options, warrants, script
rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common
Stock, or contracts, commitments, understandings or arrangements by
which the Company is bound to issue additional shares of Common
Stock or Common Stock Equivalents, in each case issued by the
Company. Except as set forth on Schedule 3.1(g)
attached hereto, the issuance and sale of the Securities will not
obligate the Company to issue shares of Common Stock or other
securities to any Person (other than the Purchasers) and will not
result in a right of any holder of Company securities to adjust the
exercise, conversion, exchange or reset price under any of such
securities. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any
stockholder, the Board of Directors or others is required for the
issuance and sale of the Securities. Except as filed as
an exhibit to the SEC Reports, there are no stockholders
agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company
is a party or, to the actual knowledge of the Company, between or
among any of the Company’s stockholders.
(h)
SEC Reports; Financial Statements . The Company
has complied in all material respects with requirements to file all
reports, schedules, forms, statements and other documents filed by
the Company under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the
Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and
documents incorporated by reference therein, together with the
Prospectus and the Prospectus Supplement, being collectively
referred to herein as the “ SEC Reports ”) on a
timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none
of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading; provided, that, the Company’s Current
Report on Form 8-K filed with the Commission on July 8, 2009
incorporated a press release dated July 7, 2009 as Exhibit 99.1 and
such press release contained certain information which was
clarified by subsequent SEC Reports filed by the Company on Forms
8-K filed with the Commission on July 23 and August 3, 2009. The
Company has never been an issuer subject to the disqualification
provisions set forth in Rule 144(i) under the Securities
Act. The financial statements of the Company included in
the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of
filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods
involved (“ GAAP ”), except as may be otherwise
specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all
footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.
(i)
Material Changes; Undisclosed Events, Liabilities or
Developments . Since the date of the latest audited
financial statements included within the SEC Reports, except as
specifically disclosed in a subsequent SEC Report filed prior to
the date hereof, (i) there has been no event, occurrence or
development that has had or that would reasonably be expected to
result in a Material Adverse Effect, (ii) the Company has not
incurred any material liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the
ordinary course of business consistent with past practice and (B)
liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed
in filings made with the Commission, (iii) the Company has not
materially altered its method of accounting, (iv) the Company has
not declared or made any dividend or distribution of cash or other
property to its stockholders or purchased, redeemed or made any
agreements to purchase or redeem any shares of its capital stock
and (v) the Company has not issued any equity securities to any
officer, director or Affiliate, except pursuant to existing Company
stock option or compensation plans. Except for the
issuance of the Securities contemplated by this Agreement or as set
forth in the SEC Reports, no event, liability or development has
occurred or exists with respect to the Company or its business,
properties, operations or financial condition, that would be
required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that
has not been publicly disclosed prior to the date that this
representation is made.
(j)
Compliance. The Company: (i) is not in default
under or in violation of (and no event has occurred that has not
been waived that, with notice or lapse of time or both, would
result in a default by the Company under), nor has the Company
received notice of a claim that it is in default under or that it
is in violation of, any indenture, loan or credit agreement or any
other agreement or instrument to which it is a party or by which it
or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is not in violation of any
judgment, decree or order of any court, arbitrator or governmental
body or (iii) is not, nor has been in, violation of any statute,
rule, ordinance or regulation of any governmental authority,
including without limitation all foreign, federal, state and local
laws applicable to its business and all such laws that affect the
environment, except in each case as would not reasonably be
expected to result in a Material Adverse Effect.
(k)
Certain Fees . Except as set forth in the
Prospectus Supplement, no brokerage or finder’s fees or
commissions are or will be payable by the Company to any broker,
financial advisor or consultant, finder, placement agent,
investment banker, bank or other Person with respect to the
transactions contemplated by the Transaction
Documents. The Purchasers shall have no obligation with
respect to any fees or with respect to any claims made by or on
behalf of other Persons for fees of a type contemplated in this
Section that may be due from the Company in connection with the
transactions contemplated by the Transaction Documents.
(l)
Investment Company . The Company is not, and is not an
Affiliate of, and immediately after receipt of payment for the
Securities, will not be or be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of
1940, as amended.
(m)
Listing and Maintenance Requirements . The Common
Stock is registered pursuant to Section 12(b) of the Exchange Act,
and the Company has taken no action designed to, or which to its
actual knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act.
(n)
Application of Takeover Protections
. The